Skip to main content

Table 1 Baseline characteristics of the study cohort

From: Anthropometric measures and the risk of developing atrial fibrillation: a Swedish Cohort Study

  Men (n = 9883) Women (16,078)
Total n: 9883 16,078
Incidence of AF, n (per 1000 p-y) 2102 (11.83) 2215 (6.98)
Age at screening (years) 59 ± 7 57 ± 8
Height (cm) 176.5 ± 6.6 164.7 ± 6.0
Weight (kg) 81.6 ± 12 67.9 ± 11.6
BMI (kg/m2) 26.2 ± 3.4 25.4 ± 4.2
BF % 20.7 ± 5 30.7 ± 5
WHR 0.94 ± 0.06 0.79 ± 0.05
WC (cm) 93.6 ± 12.7 77.7 ± 10.5
WHtR 0.53 ± 0.07 0.48 ± 0.07
Systolic Blood Pressure (mmHg) 144 ± 19 139 ± 20
leukocyte count (10^9/l) 6.37 ± 2.59 6.42 ± 2.32
Follow-up period (years) 18 ± 6.5 19.7 ± 5.3
Apo A1 (mg/dL) 145 ± 24.7 165 ± 27.6
Apo B (mg/dL) 111 ± 25.4 105 ± 26.3
High Alcohol Consumption (> 40/30 g per day for men/women) (%) 7.5 2.4
Current smoking (%) 28.8 27.9
Current use of antihypertensive medicine (%) 17.6 15.30
Use of Lipid Lowering Drugs (%) 3.3 1.80
Immigrated to Sweden (%) 11.9 11.8
Diagnosed diabetes (%) 5.0 3.1
Married (%) 72.7 60.8
Primary school education (%) 45.2 38.9
Secondary school education (%) 19.6 30.5
Higher levels of education (%) 35.2 30.6
History of coronary event (%) 2.9 1.6
History of heart failure (%) 0.4 0.2
  1. Values are means ± standard deviation, unless stated otherwise
  2. p-y person years
  3. AF Atrial Fibrillation, BMI body mass index, BF % bodyfat-percentage, WHR Waist-Hip Ratio, WC Waist Circumference, WHtR Waist-Height Ratio, Apo-A1 apoprotein A1-levels, Apo B apoprotein B-levels